Related Experiment Video
Updated: Oct 12, 2026

Biomimetic Materials to Characterize Bacteria-host Interactions
Published on: November 16, 2015
Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition
1Immunobiology Unit, Institute of Child Health, University College London, NHS Trust, London, United Kingdom.
Abstract:
Mannose-binding lectin (MBL) is a collagenous serum lectin believed to be of importance in innate immunity. Genetically determined low levels of the protein are known to predispose to infections. In this study the binding of purified MBL to pathogens isolated from immunocompromised children was investigated by flow cytometry. Diverse Candida species, Aspergillus fumigatus, Staphylococcus aureus, and beta-hemolytic group A streptococci exhibited strong binding of MBL, whereas Escherichia coli, Klebsiella species, and Haemophilus influenzae type b were characterized by heterogeneous binding patterns. In contrast, beta-hemolytic group B streptococci, Streptococcus pneumoniae, and Staphylococcus epidermidis showed low levels of binding. Bound MBL was able to promote C4 deposition in a concentration-dependent manner. We conclude that MBL may be of importance in first-line immune defense against several important pathogens.
Insights
Mannose-binding lectin (MBL) is crucial for innate immunity. This study shows MBL binds strongly to key pathogens like Candida and Staphylococcus, aiding immune defense in immunocompromised children.
Area of Science:
- Immunology
- Microbiology
- Infectious Diseases
Background:
- Mannose-binding lectin (MBL) is a key component of the innate immune system.
- Low MBL levels are associated with increased susceptibility to infections.
Purpose of the Study:
- To investigate the binding of MBL to various pathogens commonly found in immunocompromised children.
- To assess MBL's ability to promote complement activation.
Main Methods:
- Purified MBL was used to analyze binding to clinical isolates via flow cytometry.
- Complement C4 deposition was measured to assess MBL's functional activity.
Main Results:
- Strong MBL binding was observed for Candida species, Aspergillus fumigatus, Staphylococcus aureus, and beta-hemolytic group A streptococci.
- Escherichia coli, Klebsiella species, and Haemophilus influenzae type b showed heterogeneous binding.
- Beta-hemolytic group B streptococci, Streptococcus pneumoniae, and Staphylococcus epidermidis exhibited low MBL binding.
- Bound MBL effectively promoted complement C4 deposition in a dose-dependent manner.
Conclusions:
- MBL plays a significant role in the initial immune defense against a range of important human pathogens.
- These findings highlight MBL's potential as a therapeutic target for infections in immunocompromised individuals.
More Related Videos
Related Concept Videos
Selectins
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Complement System
Clinical Significance of Antibiotic Resistance

